Clarity On Drug Pricing Policy

Healthcare investors will be looking for direction today as President Trump gives a highly anticipated speech about drug prices. The plan will reportedly require Medicare Part D plans to share a portion of discounts they receive from drug manufacturers with patients, as well as including ways to allow the government to better negotiate. Amid concerns over regulation, the S&P 500 healthcare sector has declined about 1% in 2018, underperforming the broader index by more than two percentage points….

Original Source